Gastrointestinal endoscopy
September 30, 2026 · via Europe PMC
Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
Rex DK, Anderson JC, Burke CA, +5 more, Robertson DJ
AI summary — for doctors, generated from the abstract only
Serrated polyposis syndrome is common but under-recognized, raises colorectal cancer risk, and needs thorough clearance with frequent surveillance colonoscopy and screening of first-degree relatives.
What was studied
Review and consensus statement from the US Multi-Society Task Force on Colorectal Cancer on diagnosis and management of serrated polyposis syndrome.
Key findings
- Diagnosis rests on WHO clinical criteria based on serrated polyp size, number and location.
- Careful inspection, clearance and frequent surveillance are advised to reduce incident cancer.
- Surgery is for cancer or polyp burden that expert endoscopists cannot control.
- Germline testing is only for those meeting criteria for a known hereditary syndrome; first-degree relatives should have colonoscopic screening.
Clinical relevance
Gastroenterologists and endoscopists should recognize SPS, since missed diagnosis leaves patients and relatives at elevated cancer risk.
Who should care
Limitations
The abstract does not report evidence grading or specific surveillance intervals, and such consensus guidance relies on limited high-quality data.
Apply the WHO criteria when you see multiple or large serrated polyps, set up close surveillance, and offer colonoscopy to first-degree relatives.
This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates — verify against the original source before acting on it.
Abstract
Serrated polyposis syndrome (SPS) is the most common polyposis syndrome, yet SPS often goes unrecognized. SPS diagnosis is based on clinical criteria established by the World Health Organization and includes the size, cumulative lifetime number, and location of serrated polyps throughout the colon. Individuals with SPS have an increased risk of prevalent and incident colorectal cancer (CRC). Meticulous inspection, clearing of the colon and frequent surveillance colonoscopy is recommended to decrease incident CRC. Colorectal surgery is indicated for individuals diagnosed with cancer or whose polyp burden cannot be managed endoscopically by expert endoscopists. There is no common germline pathogenic variant associated with SPS. Germline genetic testing is indicated only in individuals who meet criteria for a known hereditary syndrome in the appropriate clinical setting. First-degree relatives of patients with SPS are at heightened risk of CRC and should undergo colonoscopic screening.
DOI
10.1016/j.gie.2026.09.002
PMID
42814066
Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
Back to the research feed